Plasmid News and Research

RSS
Curia unveils comprehensive mRNA solution

Curia unveils comprehensive mRNA solution

From laboratory to clinic - Nanotechnology-enabled mRNA COVID-19 vaccines

From laboratory to clinic - Nanotechnology-enabled mRNA COVID-19 vaccines

New compound could combat multidrug-resistant pathogens in healthcare settings

New compound could combat multidrug-resistant pathogens in healthcare settings

Unique nanoparticle can deliver genome editing technology to endothelial cells

Unique nanoparticle can deliver genome editing technology to endothelial cells

SARS-CoV-2 Omicron variant highly resistant to vaccine-elicited and therapeutic antibodies

SARS-CoV-2 Omicron variant highly resistant to vaccine-elicited and therapeutic antibodies

At least 3 exposures to vaccine or virus needed for minimum protection against SARS-CoV-2 Omicron

At least 3 exposures to vaccine or virus needed for minimum protection against SARS-CoV-2 Omicron

Exploring the plasma neutralization properties of the Omicron variant of SARS-CoV-2

Exploring the plasma neutralization properties of the Omicron variant of SARS-CoV-2

Evaluation of SARS-CoV-2 neutralizing antibodies in mothers and infants

Evaluation of SARS-CoV-2 neutralizing antibodies in mothers and infants

Researchers introduce new method for observing cell interactions

Researchers introduce new method for observing cell interactions

Severe COVID-19 may result in premature aging in recovered patients

Severe COVID-19 may result in premature aging in recovered patients

Antigenic cocktail produced in Nicotiana benthamian plant as a potential COVID-19 vaccine candidate

Antigenic cocktail produced in Nicotiana benthamian plant as a potential COVID-19 vaccine candidate

A nasal COVID vaccine using a weakened influenza vector

A nasal COVID vaccine using a weakened influenza vector

Novel strategy to produce SARS-CoV-2 nucleocapsid protein for serological testing

Novel strategy to produce SARS-CoV-2 nucleocapsid protein for serological testing

Interactions between SARS-CoV-2 S protein and ACE2 receptor using fluorescence correlation spectroscopy

Interactions between SARS-CoV-2 S protein and ACE2 receptor using fluorescence correlation spectroscopy

Discovery of new receptor that interacts with SARS-CoV-2 spike, suppresses infection

Discovery of new receptor that interacts with SARS-CoV-2 spike, suppresses infection

SARS-CoV-2 Nsp1 deletions affect protein stability and translation inhibition

SARS-CoV-2 Nsp1 deletions affect protein stability and translation inhibition

Study finds SARS-CoV-2 infection is proportional to cell surface ACE2 levels

Study finds SARS-CoV-2 infection is proportional to cell surface ACE2 levels

Replication of SARS-CoV-2 variants in different cell and organ models

Replication of SARS-CoV-2 variants in different cell and organ models

Suggested mechanism of SARS-CoV-2 infection inhibition by Mitoxantrone

Suggested mechanism of SARS-CoV-2 infection inhibition by Mitoxantrone

Two defense systems in bacteria work in a complementary manner to protect from viruses

Two defense systems in bacteria work in a complementary manner to protect from viruses